Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)-Reference-Cited by-同舟云学术

Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)

Published:2023-09 Issue: Volume:35 Page:101706
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Menzel Michael^ORCID,Endris Volker,Schwab Constantin,Kluck Klaus,Neumann Olaf^ORCID,Beck Susanne,Ball Markus,Schaaf Christian,Fröhling Stefan^ORCID,Lichtner Peter,Schirmacher Peter,Kazdal Daniel,Stenzinger Albrecht,Budczies Jan^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer;Moschetta;Ann. Oncol.,2016

2. Integrated genomic analyses of ovarian carcinoma;Nature,2011

3. Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD);Rempel;NPJ Precis. Oncol.,2022

4. Incorporating parp-inhibitors in primary and recurrent ovarian cancer: a meta-analysis of 12 phase II/III randomized controlled trials;Ruscito;Cancer Treat. Rev.,2020

5. PARP inhibitors in the management of ovarian cancer: ASCO guideline;Tew;J. Clin. Oncol.,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benchmarking Whole Exome Sequencing in the German Network for Personalized Medicine;European Journal of Cancer;2024-09

2. Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in Tumor;The Journal of Molecular Diagnostics;2024-06

3. Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors;The Journal of Pathology: Clinical Research;2024-01-17

4. Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay;International Journal of Molecular Sciences;2023-12-04

5. Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients;npj Precision Oncology;2023-10-20